BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li J, Wang M, Zhang B, Wu X, Lin TL, Liu XF, Zhou Y, Zhang XH, Xu H, Shen LJ, Zou J, Lu P, Zhang D, Gu WJ, Zhang MX, Pan J, Cao H, Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association. Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors. World J Gastroenterol 2018; 24(46): 5189-5202 [PMID: 30581268 DOI: 10.3748/wjg.v24.i46.5189]
URL: https://www.wjgnet.com/1007-9327/full/v24/i46/5189.htm
Number Citing Articles
1
Hao Xu, Qi Liu. Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal TumorsOncoTargets and Therapy 2021; : 13345 doi: 10.2147/OTT.S279998
2
Michał Miner, Michał Elbaum, Aleksandra Jawiarczyk-Przybyłowska, Eliza Kubicka. Endocrine complications of new anticancer therapiesPostępy Higieny i Medycyny Doświadczalnej 2021; 75: 191 doi: 10.5604/01.3001.0014.8121
3
Jian Wang, Yuan Yin, Chaoyong Shen, Xiaonan Yin, Zhaolun Cai, Lin Pu, Wei Fu, Yaxuan Wang, Bo Zhang. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumorsMedicine 2020; 99(9): e19275 doi: 10.1097/MD.0000000000019275